With recent quarterly results over, I was surprised to find two of my REITs looked poised for more potential upside.
Beyond headlines, I delved deeper into what investors may have missed from their recent earnings below. Let’s dive in.
1. Parkway Life REIT
Other than eye-catching numbers: “PLife REIT reports higher 1H2026 DPU of 14.6% supported by resilient organic growth”, there are other positive observations:
- Singapore Hospitals – Hidden rental upside from new rental formula and revenue sharing with master lessee
Rent review and escalation formula kicks in: Long time PLife REIT unitholders would recall back in 2021, PLife REIT agreed with its Master lessee, healthcare giant – IHH Healthcare to extend their Master Lease Agreement for another 20 years until 2042, with an option to renew for a further 10 years.
Under the agreement, PLife REIT and IHH would jointly inject capital expenditure to revamp the 3 Singapore hospitals (Mount Elizabeth, Gleneagles and Parkway East hospitals), with PLife REIT granting rent rebate to IHH during the refurbishment downtime.
In exchange, IHH agreed to the rental formula and escalation to pay PLife REIT to continue operating the three hospitals, and IHH granted PLife REIT the right of first refusal to acquire their crown jewel – Mount E Novena Hospital.
Following the recent completion of refurbishment, PLife REIT can cease its three-year rent rebate to IHH. The activation of the new Consumer Price Index (CPI)-linked rent review formula from FY2026 also lifted distributable income, the 3 hospitals’ rent formula guarantees a sharp step-up in FY2026.
From FY2026, minimum rent rose 24.3% to S$99.1m, with CPI fixed at 0.9%. This adds a structural uplift for PLife REIT’s future rental structure.
Revenue-sharing uplift: After stronger performance from Gleneagles and Parkway East hospitals, 1Q2026 delivered $0.8M extra rent under the revenue sharing arrangement.
However, this upside was deferred and will only be distributed in 2H 2026. In addition, revenue sharing contribution from 2Q2026, will be recognised in 2H2026.
This means the 8.77 cents DPU currently reported in PLife REIT’s 1H2026 results (14.6% increase) has not even captured the full potential of hospitals performance above the minimum rent floor.
This upside will flow through in 2H2026 and is definitely a positive catalyst!
- Japan Portfolio – Strategic Rejuvenation and portfolio optimisation
While its Japan gross revenue fell due to JPY depreciation, PLife REIT hedged net income until 2029, so any forex headwinds are offset by forward contract gains.
In addition, as with PLife REIT’s great track record of divesting properties at a premium, it also sold a Japan nursing home at 38% above cost and at 5% above valuation, booking a gain of S$0.6M.
Heartened to know management is actively recycling assets at premiums, acquiring better properties and strengthening long-term portfolio quality.
- Balance Sheet Strength
With a gearing of merely 33.8%, PLife REIT has one of the lowest gearing among S-REITs! In addition, with an interest coverage of 8.2x (1 of the highest for S-REITs) and an overall cost of debt of only 1.67% (even pedigree Singapore REITs haven’t been able to achieve this).
These metrics means PLife REIT has the financial muscle to acquire more properties to increase its revenue.
It could intensify its entry into the France nursing home market or buy the long-awaited Mount E Novena hospital, I look forward to PLife REIT’s moves to turbo-charge its non-stop dividends growth (see below) since IPO!
Next, UI Boustead REIT
2. UI Boustead REIT
UI Boustead REIT (“UIB REIT”) was recently listed in March 2026. You can find the analysis of its IPO here.
UIB REIT recently announced its results and investors skimming through the news may frown at UIB REIT posting NPI of S$29.2 million, 4.3% below IPO forecast.
However, dig deeper and one would realise the REIT has quietly built a multi-engine growth story through organic growth and inorganic expansion.
- Co-development strategy and transformation
In April 2026, UIB REIT announced that it would co-invest with its Sponsor and partners to develop a logistics property in Konan City, Japan (UIB Konan Phase 3).
UIB REIT would hold ~24% interest in the property, with an option to fully acquire it. This maiden investment aligns with its growth strategy to participate in co-development opportunities to capture attractive upside and leverages on its Sponsor’s specialisation capabilities and local knowledge.
This development opportunity allows UIB REIT to secure an attractive entry yield of ~4.8% (higher than its Japan portfolio yield of ~3.6%). Who doesn’t love a great deal, right?
Closer to home, in May 2026, UIB REIT announced its second co-investment to build a specialised facility of 252,000 sq ft in Singapore’s Seletar Aerospace Park.
Management had secured a leading aerospace giant to lease the yet to be built facility on a 22.5-year long term lease (with build in rental escalations), locking in income visibility and stability.
At a development cost of ~$104M, UIB REIT’s 51% interest translates to an investment value of ~$54M, with an option to purchase the balance 49% interest.
Coincidentally, aerospace giant Bombardier announced its $100M expansion in Seletar on a 250,000 sq ft facility with a local developer. Guess who?
This co-development leverages on its Sponsor, Boustead’s specialisation in Built-To-Suit (BTS) developments. Investing in the facility allows the REIT to secure an attractive yield on cost of ~8.6% (higher than its Singapore portfolio yield of ~7.4%).
Some investors may be concerned about REITs taking on development roles. However, UIB REIT’s combined investment of $74.7 m (3.9% of deposited property) sits comfortably within MAS development limits of 10%, and I believe this is manageable yet yields upside potential for UIB REIT.
- Japan Portfolio –Growth Catalyst and Filling of occupancy
During the IPO, there were concerns about UIB REIT’s low occupancy of 76.7% for its Japan portfolio. However, I was delighted to note that management has since achieved 100% occupancy (see chart below).
The long WALE of 7.5 years also ensures long-term income visibility. Japan is morphing into a growth engine with development upside and long-term leases.
- Singapore Portfolio – Early Signs of Rental Repricing
UIB REIT managed to achieve positive rental reversion of ~2.6% across its Business Space and Hi-Specs Industrial segments.
The REIT is also converting its single tenanted property at 84 Boon Keng Road into multi-tenanted use, and secured 40% pre-committed leasing.
UIB REIT also secured a global F&B chain as anchor tenant for its 26 Tai Seng property, lifting Singapore’s occupancy to 97%.
Consequently, UIB REIT’s overall portfolio occupancy jumped from 89.4% at IPO in March 2026 to 98.1% by June 2026.
My final thoughts
With the positive factors above, and its stellar record of ~400% returns since IPO in 2007 (price appreciation + dividends collected), I am convinced PLife REIT is primed to bring me more upside growth in years to come!
UIB REIT’s two co-developments embed future revenue growth, differentiates it from other industrial REITs and showcases its synergy with its Sponsor’s niche BTS capabilities.
Management’s moves to unlock rental reversion upside, and AEI-driven leasing could raise dividend yields. While it is still early days for this young REIT, I believe the future looks bright for UIB REIT!
